Search Results 741-750 of 15238 for alt

1. A Study to Evaluate the Effectiveness and Safety of Remdesivir to Treat Coronavirus Disease 2019 in an Outpatient Setting - Mayo Clinic

   ALT or AST ≥ 5 × upper limit of normal ... Note: if per local practice only ALT is routinely measured, exclusion criteria will be evaluated on ALT alone.

2. Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma - Mayo Clinic

   ALT******* < 3 × ULN. Abbreviations: ALT = alanine aminotransferase; ANC = absolute neutrophil count; AST = aspartate aminotransferase; BM = bone marrow; INR ...

3. Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery - Mayo Clinic

   SGPT (ALT) ≤2.5 x ULN, if subject has HCC or liver metastases ≤5 x ULN; Creatinine ≤1.5 x ULN; INR ≤1.5 x ULN. Patients receiving anti-coagulation therapy ...

4. A Study of Adjunctive Ganaxolone Treatment in Children and Young Adults with CDKL5 Deficiency Disorder - Mayo Clinic

   ... [ALT]) and hematology during the course of treatment, and is expected to remain constant throughout the double-blind phase. 10. Parent/caregiver is able and ...

5. An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies - Mayo Clinic

   AST or ALT > 1.5 × ULN; ALP > 1.5 × ULN (> 3 × ULN if related to underlying disease); Creatinine clearance ≤60 mL/min based on the site's standard formula ...

6. A Clinical Study Of KTX-2001 In Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

   ... ALT ≤2.5× ULN). In case of liver metastases, AST and ALT <5× ULN is allowed. Adequate hematological function (neutrophils >1 × 109/L, platelet count >100 ...

7. Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors - Mayo Clinic

   Adequate hepatic function: AST and ALT <2.5 x ULN, Total and Direct Bilirubin <1.5 x ULN. However, in the presence of liver metastases, AST and ALT must be <5 x ...

8. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

9. A Study of ASTX660 Alone or Combined with ASTX727 in Subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) - Mayo Clinic

   Alanine aminotransferase (ALT) ≤ 2.5 × ULN;; Bilirubin ≤ 1.5 × ULN - unless considered due to leukemic organ involvement. Women of child-bearing potential ...

10. Protein-bound Paclitaxel, Cisplatin, And Gemcitabine (GCN) Combined With Tumor Treatment Fields (TTF) In Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    ... (ALT) or aspartate aminotransferase (AST) < 3 x ULN;; For patients with known liver metastases or liver neoplasms: alanine aminotransferase (ALT) or ...